TrialJournal of Korean medical science2015

A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease.

Jin-Ho Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.